HQL News and Press, TeklaLife Sciences Investors From 10/27/23

HQH , HQL , THQ , THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic cl...

Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds). The Funds are: Tekla Healthcare Investors (HQH) Tekla Life Sciences Inve...

2023-10-17 07:34:32 ET Summary Closed-end funds are currently trading at historically deep discounts, with the average discount at -9.64% at the end of Q3 2023. Municipal bond funds are experiencing particularly wide discounts, with an average discount of -12.89%. Non-leverage...

2023-10-17 00:31:01 ET Summary The number of CEFs currently in the U.S. market is 440, each one acting as a spokesperson for the strategy and management philosophy of the houses that launched them. The reason why most investors are interested in CEFs is because they provide a stea...

Tekla Healthcare Investors (HQH) today announced at the Special Meetings of shareholders (“Special Meetings”) that the requisite vote had been attained for the proposal to approve the new investment advisory agreement with abrdn Inc. However, while the proposal has now been pass...

Tekla Life Sciences Investors (HQL) announced at the Joint Special Meetings of shareholders (“Special Meetings”) that the requisite vote had been reached to approve the new investment advisory agreement with abrdn Inc. At the same Special Meetings, shareholders are voting with o...

2023-09-27 14:34:01 ET Summary Tekla Life Sciences Investors invests primarily in biotechnology stocks, and 10-12 large-cap biotech stocks (50% of total holdings) sets the trend and price direction for this fund. Poor price growth of biotech stocks thus has resulted in a huge pric...

Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special meetings of shareholders (“Special Meetings”) were adjou...

2023-09-06 15:08:20 ET Summary Tekla Capital manages four healthcare-focused closed-end funds. Of the four funds, I continue to believe the Tekla Healthcare Opportunities Fund is the most attractive, as its distribution yield appears most sustainable. A pending merger between ...

Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special meetings of shareholders (“Special Meetings”) were a...